Home
>
National Drug Code (NDC)
>
ZOSTAVAX
ZOSTAVAX - 0006-4963-41 - (Zoster Vaccine Live)
Drug Information of ZOSTAVAX
| Product NDC: | 0006-4963 |
| Proprietary Name: | ZOSTAVAX |
| Non Proprietary Name: | Zoster Vaccine Live |
| Active Ingredient(s): | 19400 [PFU]/.65mL & nbsp; Zoster Vaccine Live |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ZOSTAVAX
| Product NDC: | 0006-4963 |
| Labeler Name: | Merck Sharp & Dohme Corp. |
| Product Type: | VACCINE |
| FDA Application Number: | BLA125123 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20060525 |
Package Information of ZOSTAVAX
| Package NDC: | 0006-4963-41 |
| Package Description: | 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4963-41) > .65 mL in 1 VIAL, SINGLE-DOSE (0006-4963-01) |
NDC Information of ZOSTAVAX
| NDC Code | 0006-4963-41 |
| Proprietary Name | ZOSTAVAX |
| Package Description | 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4963-41) > .65 mL in 1 VIAL, SINGLE-DOSE (0006-4963-01) |
| Product NDC | 0006-4963 |
| Product Type Name | VACCINE |
| Non Proprietary Name | Zoster Vaccine Live |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20060525 |
| Marketing Category Name | BLA |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN |
| Strength Number | 19400 |
| Strength Unit | [PFU]/.65mL |
| Pharmaceutical Classes | Live Attenuated Varicella Zoster Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Chickenpox Vaccine [Chemical/Ingredient],Live Attenuated Herpes Zoster Virus Vaccine [EPC],Herpes Zoster Vaccine [Chemical/Ingredient] |
